| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcus Biosciences, Inc. (RCUS) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. RCUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.16M | $54.50M | - | |
| Pres | 922.2K | $23.30M | - | |
| COO | 193.0K | $4.88M | - | |
| Other | 124.7K | $3.15M | - | |
| Dir | 71.0K | $1.79M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Rosen Terry J72 | Chief Executive Officer | Buy | 19,800 | $10.18 | $201,465.00 | +0.8% | -7.6% | +106.2% | |
| Feb 27, 2025 | Kaneko Yasunori | Director | Buy | 20,000 | $10.06 | $201,200.00 | +238.1% | -7.6% | +106.2% | |
| Dec 31, 2024 | Goeltz II Robert C.72 | Chief Financial Officer | Sell | 3,594 | $15.00 | $53,910.00 | -5.6% | -47.3% | +60.0% | |
| Dec 2, 2024 | Azoy Alexander64 | Chief Accounting Officer | Sell | 201 | $15.32 | $3,079.32 | -1.0% | -34.1% | +59.5% | |
| Aug 13, 2024 | Azoy Alexander64 | Chief Accounting Officer | Sell | 1,357 | $14.97 | $20,314.29 | -6.6% | +13.5% | -35.7% | |
| Mar 27, 2024 | Jarrett Jennifer74 | Chief Operating Officer | Sell | 11,551 | $17.55 | $202,720.05 | -5.1% | -13.1% | -53.4% | |
| Mar 18, 2024 | Jarrett Jennifer74 | Chief Operating Officer | Sell | 13,449 | $17.92 | $240,941.04 | -2.9% | -5.9% | -47.8% | |
| Feb 27, 2024 | Jarrett Jennifer74 | Chief Operating Officer | Sell | 58,625 | $20.09 | $1,177,966.55 | -10.2% | -22.3% | -49.8% | |
| Feb 27, 2024 | Jaen Juan C.75 | President | Sell | 27,032 | $20.09 | $543,187.20 | -1.1% | -22.3% | -49.8% | |
| Jan 2, 2024 | Goeltz II Robert C.72 | Chief Financial Officer | Sell | 2,004 | $20.00 | $40,080.00 | -3.7% | -6.1% | -23.1% |